Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Prostatic Neoplasms 2 Liver Neoplasms 2 Endometrial Neoplasms 2 Uterine Cervical Neoplasms 1 Soft Tissue Neoplasms 1 Sarcoma 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Liver Diseases 1 Inflammatory Breast Neoplasms 1 Hypersensitivity 1 Colorectal Neoplasms 1 Chronic Pain 1 Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 80 Oxaliplatin 72 Leucovorin 66 Irinotecan 60 Capecitabine 58 Bevacizumab 57 Cetuximab 43 Folfox protocol 22 Drug Therapy 22 Neoadjuvant Therapy 19 HMPL-013 17 Colonoscopy 17 regorafenib 15 apatinib 11 Panitumumab 11 Chemotherapy, Adjuvant 11 trifluridine tipiracil drug combination 10 XELOX 10 Laparoscopy 10 IFL protocol 10 sintilimab 9 raltitrexed 9 Radiotherapy 9 Blood Specimen Collection 9 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 tislelizumab 7 pembrolizumab 7 Endoscopic Mucosal Resection 7 Aspirin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × High-Energy Shock Waves × Clear all

NCT01516710 2024-05-10

Oslo-CoMet

Oslo University Hospital

Phase NA Unknown

280 enrolled 8 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡